Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Volastra
Research
Mitochondrial free radicals spur micronuclear collapse in cancer
Two studies explain in mechanistic detail how micronuclei rupture and collapse in cancer cells, an important process that drives cancer progression.
Darren Incorvaia
Aug 29, 2024 2:00pm
Volastra buys clinical cancer med from Amgen, tacks on $60M
Mar 7, 2023 7:00am
Fierce Biotech's 2022 Fierce 15
Sep 12, 2022 3:00am
Arch raises nearly $3B amid cratering biotech market
Jun 29, 2022 11:15am
Dewpoint snags $150M for programs with Pfizer, Merck and Bayer
Feb 3, 2022 6:00am
Volastra bumps up seed round to $44M, inks Microsoft partnership
Apr 6, 2021 7:00am
